# GlucoTwin AI - Phase Status Tracking

**Current Phase:** Phase 2 - Architecture and Contracts  
**Status:** Completed  
**Last Updated:** October 20, 2026  

---

## 1. Phase Progression Overview

| Phase | Description | Status | Completion Date | Exit Criteria Met |
| :--- | :--- | :--- | :--- | :--- |
| **Phase 1** | **Workspace Inspection and Setup** | **Completed** | **2026-10-20** | **Yes (5/5)** |
| **Phase 2** | **Architecture and Contracts** | **Completed** | **2026-10-20** | **Yes (4/4)** |
| **Phase 3** | Synthetic Patient Data Generator & Telemetry Ingestion | Pending Approval | — | — |
| **Phase 4** | Glycemic Metrics & Ambulatory Glucose Profile Engine | Not Started | — | — |
| **Phase 5** | Digital Twin Physiological ODE & ARX-Kalman Engine | Not Started | — | — |
| **Phase 6** | What-If Counterfactual Simulator & Safety Guardrails | Not Started | — | — |
| **Phase 7** | Frontend Web Dashboard & Interactive AGP Visualizer | Not Started | — | — |
| **Phase 8** | End-to-End Integration, Security Audit & QA Verification | Not Started | — | — |

---

## 2. Phase 2 Implementation Summary

- **Architecture Specification (`docs/architecture.md`):** Complete system architecture defining FastAPI backend boundaries, React/Vite communication, 4-tier data segregation barrier, response/abstention envelopes, patient-level splitting, and artifact versioning with SHA-256 checksums.
- **Visual Architecture Model (`docs/architecture-diagram.mmd`):** Full Mermaid diagram visualizing client, gateway, ingestion, core engines (Bergman Minimal Model ODE + ARX-Kalman), data segregation barrier, clinical refusal guardrail, and persistence layer.
- **Database Data Dictionary (`docs/data_dictionary.md`):** Definitive table schemas for `users`, `synthetic_patients`, `telemetry_records` (Tier 1 Observed), `glycemic_metrics` (Tier 2 Derived), `forecast_runs` (Tier 3 Predicted), `simulation_scenarios` (Tier 4 Hypothetical), and `audit_logs`, with primary/foreign keys, cascade rules, check constraints, composite time-series indexes, and Alembic migration strategy.
- **Single Configuration Specification (`docs/config_specification.md`):** Canonical source of truth establishing physical units (`mg/dL`, `grams`, `synthetic_units`, `min`, `kg`), clinical thresholds (TIR `[70.0, 180.0]`, Hypo L1 `<70.0`, Severe Hypo L2 `<54.0`, Hyper L1 `>180.0`, Severe Hyper L2 `>250.0`, Physiological bounds `[40.0, 500.0]`), forecast horizons (15, 30, 45, 60 min), telemetry freshness limit (15 min), and context history requirements (min 60 min).
- **REST API Contracts (`docs/api_contracts.md`):** Comprehensive REST specifications for Auth, Patients, Telemetry, Metrics, Twin Forecasting, What-If Simulation, Guardrails, and Health, including success, error, and abstention envelopes with HTTP status codes.
- **Feature Engineering Schema (`docs/feature_schema.md`):** Detailed input feature definitions, lag structures ($G_{t-1 \dots 12}$), velocity/acceleration, Carbs on Board ($COB$), Insulin on Board ($IOB$), Activity Strain ($ACT$), circadian sine/cosine embeddings, normalization equations, and missing-data imputation boundaries.
- **Evaluation Protocol (`docs/evaluation_protocol.md`):** Scientific validation framework detailing 70/15/15 patient-level cohort splitting, zero cross-patient and zero temporal leakage rules, quantitative metrics (RMSE, MAE, MARD), Consensus/Clarke Error Grid Analysis (Zones A–E), and fail-closed abstention metrics.
- **Security & Threat Model (`docs/threat_model.md`):** STRIDE threat assessment with trust boundaries, mitigation matrices, and dedicated Clinical Misuse threat analysis (preventing user reliance on simulations for insulin dosing via outbound refusal filters and prominent disclaimers).
- **Risk and Limitations (`docs/risk_and_limitations.md`):** In-depth physiological breakdown of the Bergman Minimal Model and ARX transfer function assumptions, subcutaneous vs interstitial lag (5–15 min), unmodeled hormonal dynamics, and fail-closed operational triggers.
- **Initial Model Card Template (`docs/model_card.md`):** Model card template for `glucotwin-arx-kalman-v1.0.0` and `glucotwin-bergman-ode-v1.0.0`, explicitly marking all quantitative evaluation metrics as `[UNMEASURED - Pending Phase 5 Benchmark Training]` without inventing results.

---

## 3. Actual Commands Executed & Outputs

1. `write_to_file` on all 10 documentation specifications in `docs/`.
2. Python consistency check script `verify_phase2_consistency.py` executed:
   - Command: `py -3.12 verify_phase2_consistency.py`
   - Initial run identified minor threshold formatting discrepancies in `data_dictionary.md` and missing role mentions in `threat_model.md`.
   - Discrepancies reconciled and re-verified.
   - Final run output: `=== ALL 10 DOCUMENTS ARE CONSISTENT AND COMPLIANT ===` (Exit Code: 0).
3. `git add docs/ ; git commit -m "docs: complete Phase 2 architecture and contracts specifications"` -> Committed baseline contracts (Commit `5e89a2b`).
4. `git status` -> Working tree verified clean.

---

## 4. Tests Passed and Failed

- **Cross-Document Specification Consistency Suite:** **100% Passed (10/10 files verified)**
  - Physical unit agreement (`mg/dL`, `grams`, `synthetic_units`, `min`): PASSED
  - Glycemic threshold agreement (70.0, 180.0, 54.0, 250.0, 40.0, 500.0): PASSED
  - Authentication role alignment across all schemas (`researcher`, `clinician_observer`, `auditor`): PASSED
  - Standard abstention codes across architecture, API contracts, and risk documents: PASSED
  - 4-Tier data segregation verification across architecture and data dictionary: PASSED
  - Unmeasured metrics integrity in model card (no fabricated metrics): PASSED

---

## 5. Known Issues & Residual Risks

1. **Synthetic vs In-Vivo Physiological Gap:**
   - *Risk:* The Bergman Minimal Model simplifies human multi-organ glucose kinetics into 3 compartments, and CGM sensors have an inherent 5–15 minute interstitial fluid lag.
   - *Documentation:* Thoroughly documented in `docs/risk_and_limitations.md`.
2. **Clinical Misuse Hazard:**
   - *Risk:* Potential user overreliance attempting to use educational what-if simulations for real insulin dosing.
   - *Mitigation:* Hardcoded outbound regex/token refusal filter (`guardrails.py`), unclosable UI disclaimer banners, and zero dosing calculation algorithms.

---

## 6. Files Created or Modified in Phase 2

- `docs/architecture.md` (Created)
- `docs/architecture-diagram.mmd` (Created)
- `docs/data_dictionary.md` (Created)
- `docs/config_specification.md` (Created)
- `docs/api_contracts.md` (Created)
- `docs/feature_schema.md` (Created)
- `docs/evaluation_protocol.md` (Created)
- `docs/threat_model.md` (Created)
- `docs/risk_and_limitations.md` (Created)
- `docs/model_card.md` (Created)
- `PHASE_STATUS.md` (Updated)

---

## 7. Exact Acceptance Criteria Verification

- [x] **Documents agree with one another:** Verified via automated Python script checking units, thresholds, roles, abstention codes, and tiers across all 10 documents.
- [x] **Every critical entity and API has a defined contract:** Database tables, Pydantic schemas, and REST endpoints (Auth, Patients, Telemetry, Metrics, Forecast, Simulation, Guardrails, Health) fully specified.
- [x] **Threats and residual risks are documented:** STRIDE matrix, clinical misuse analysis, and physiological limitations comprehensively detailed.
- [x] **Phase 3 can implement the agreed architecture without guessing:** Entity schemas, synthetic patient parameters, data structures, and constraints are explicitly defined down to column types, check constraints, and JSON schemas.

---

## 8. Next Phase to Execute

**Phase 3: Synthetic Patient Data Generator & Telemetry Ingestion**
- Implement deterministic in-silico Type 1 Diabetes patient generator (`app/services/synthetic_data.py`).
- Implement Pydantic v2 schemas for synthetic patient creation and telemetry ingestion.
- Implement telemetry batch ingestion endpoint (`POST /api/v1/patients/{id}/telemetry`) with rate-of-change computation and physiological sanity bounds checking ($[40.0, 500.0] \text{ mg/dL}$).
- Implement Alembic migrations and database tables for `users`, `synthetic_patients`, `telemetry_records`, and `audit_logs`.
- Build Pytest test suite for patient generator determinism, schema validation, and fail-closed telemetry filtering.
- Verify Phase 3 exit criteria before proceeding to Phase 4.
